Results 111 to 120 of about 14,201 (176)

Phage therapy and the microbiome in hematologic malignancies: opportunities, mechanisms, and early evidence. [PDF]

J Cancer Res Clin Oncol
Zhang J, Liu J, Bayani A.
europepmc   +1 more source

Hypervariable DNA fingerprinting in Escherichia coli: minisatellite probe from bacteriophage M13

, 1989
Bing Huey, Jeff Hall
openalex   +2 more sources

The enteric DNA virome differs in infants at risk for atopic disease. [PDF]

Gut Microbes
Perdue TJ, Newkirk CE, Beblavy R, Seppo AE, Davis EC, Sohn MB, Järvinen KM, Monaco CL.   +7 more
europepmc   +1 more source

Microplastics of Broad Size Range Reduce Bacteriophage Activity in Aqueous Environments. [PDF]

J Phys Chem B
Ochirbat E, Zbonikowski R, Folga M, Bonarowska M, Paczesny J.   +4 more
europepmc   +1 more source

Expression of bacteriophage M13 DNA: the in vivo transcription process

, 1982
M.A. Smits
openalex   +1 more source

M13 phages engineered with chlamydia phage φCPG1 protein IN5 and arginine-glycine-aspartic acid inhibits Chlamydia trachomatis intracellular growth. [PDF]

Virus Res
You C, Wang M, Wang J, Lian T, Liu Q.
europepmc   +1 more source

Oligonucleotide-directed mutagenesis of gene IX of bacteriophage M13

, 1982
G. Simons, G.H. Veeneman, R.N.H. Konings, Jacques H. van Boom, J.G.G. Schoenmakers   +4 more
openalex   +2 more sources

Bacteriophages as vaccine platforms: Opportunities and challenges in translation. [PDF]

Hum Vaccin Immunother
Chen W, Peters DL, Lam S, Kettal M.
europepmc   +1 more source

Bacteriophages as Targeted Therapeutic Vehicles: Challenges and Opportunities. [PDF]

Bioengineering (Basel)
Venkataraman S, Shahgolzari M, Yavari A, Hefferon K.   +3 more
europepmc   +1 more source

Illegitimate recombination at the replication origin of bacteriophage M13.

, 1986
B. Michel, S. Dusko Ehrlich
openalex   +2 more sources